In this same investigation, when compared with control subjects, immunohistochemical analyses of hippocampal tissue from AD patients revealed higher levels of the SPM receptors, ALX/FPR2 and ChemR23, the latter a receptor for RvE1. Here, FPR2 is linked to Alzheimer disease.